Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Cracow, Poland.
Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Cracow, Poland.
Transplant Proc. 2024 May;56(4):781-785. doi: 10.1016/j.transproceed.2024.02.004. Epub 2024 Mar 6.
The knowledge and attitudes of dialyzed patients toward the best method of renal replacement treatment (ie, kidney transplantation [KTx]) may be the main factor motivating them to apply and be put on the national kidney transplant waiting list, resulting in a better prognosis.
Assessment of the knowledge and attitudes of dialyzed patients toward KTx.
A pilot study is considered an introductory step before the nationwide project, which will cover dialysis centers in Poland from 2023 to 2024. The authorship 4-part questionnaire, including self-assessment knowledge, attitude dimension, pain and mental evaluation section, was made available to 30 patients with hemodialysis aged 30 to 75 years.
The median age of the patients was 59 years. The primary cause of end-stage renal disease (ESRD) was glomerulonephritis (33%). Most of the patients stayed on hemodialysis for 2 years or less (57%); 43% of the patients declared insufficient knowledge in the field of KTx, 41% of the patients were not informed at the nephrology clinic that KTx remains one of the methods of renal replacement therapy, and 65% did not receive information about the possibility of preemptive or early transplantation from a relative donor. Only 34% of the patients considered KTx to be a much better treatment option than dialysis, but only 20% of those were on the national waiting list for KTx.
The pilot study showed insufficient knowledge of patients with ESRD regarding kidney transplantation as a method of renal replacement therapy. There is a need to introduce an effective educational program.
透析患者对最佳肾脏替代治疗方法(即肾移植[KTx])的知识和态度可能是促使他们申请并被列入国家肾脏移植等待名单的主要因素,从而带来更好的预后。
评估透析患者对 KTx 的知识和态度。
这项试点研究被认为是 2023 年至 2024 年在波兰透析中心开展全国性项目的前期步骤。作者制定了一个包含 4 部分的问卷,包括自我评估知识、态度维度、疼痛和心理评估部分,共 30 名年龄在 30 至 75 岁之间的血液透析患者参与了这项研究。
患者的中位年龄为 59 岁。终末期肾病(ESRD)的主要病因是肾小球肾炎(33%)。大多数患者接受血液透析的时间在 2 年或以下(57%);43%的患者表示对 KTx 领域的知识了解不足,41%的患者在肾病科诊所未被告知 KTx 仍然是肾脏替代治疗方法之一,65%的患者未从亲属供体处获得关于优先或早期移植的可能性的信息。只有 34%的患者认为 KTx 是比透析更好的治疗选择,但只有 20%的患者在国家 KTx 等待名单上。
试点研究表明,ESRD 患者对 KTx 作为肾脏替代治疗方法的知识了解不足,需要引入有效的教育计划。